Cell separation: Terminology and practical considerations

Journal of Tissue Engineering

Volumn 4, Issue 1, 2013, Pages 1-14

  Tomlinson, Matthew J ^a   Tomlinson, Sophie ^a   Yang, Xuebin B ^a,b   Kirkham, Jennifer ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

Cell clusters; Cell separation; Cell sorting; Dead cells; Terminology; Tissue preparation

Indexed keywords

CELL ENGINEERING; CELL PROLIFERATION; FLUORIDATION; MOLECULAR BIOLOGY; SEPARATION; STATISTICS; TERMINOLOGY; TISSUE; TISSUE ENGINEERING;

BIOLOGICAL RESEARCH; CELL CLUSTERS; CELL SEPARATION; CELL SORTING; DEAD CELLS; DIVERSE RANGE; REGENERATIVE MEDICINE; SEPARATION TECHNOLOGIES; TISSUE PREPARATION; TISSUES ENGINEERINGS;

CELL CULTURE;

5' NUCLEOTIDASE; CD19 ANTIGEN; CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ENDOGLIN; NERVE GROWTH FACTOR RECEPTOR;

ANTIGEN BINDING; APHERESIS; CELL ADHESION; CELL CLUSTER; CELL DENSITY; CELL SELECTION; CELL SEPARATION; CELL THERAPY; CELL VIABILITY; CELLULAR PARAMETERS; COST; DEAD CELL; DENSITY GRADIENT CENTRIFUGATION; DISSOCIATION; ELECTROPHORESIS; FIELD FLOW FRACTIONATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LAB ON A CHIP; MAGNETIC ACTIVATED CELL SORTING; PHYSICAL PARAMETERS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PURITY; RECEPTOR BINDING; RECEPTOR STIMULATION; RECOVERY; REVIEW; STIMULATION; TISSUE PREPARATION;

EID: 84890141549     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731412472690     Document Type: Review

References (96)

1. Guo KT, Schafer R, Paul A, et al. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 2006; 24: 2220-2231.
2. Takaishi S, Okumura T, Tu SP, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020.
3. Terry VH, Johnston ICD and Spina CA. CD44 microbeads accelerate HIV-1 infection in T cells. Virology 2009; 388: 294-304.
4. Handgretinger R, Lang P, Schumm M, et al. Isolation and transplantation of autologous peripheral CD34(+) progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998; 21: 987-993.
5. To LB, Haylock D, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
6. Mancardi G and Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008; 7: 626-636.
7. Stamm C, Westphal B, Kleine H-D, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-46.
8. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
9. Lanzoni G, Alviano F, Marchionni C, et al. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. Cytotherapy 2009; 11: 1020-1031.
10. Ackerman SJ, Liu L, Kwatia MA, et al. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002; 277: 14859-14868.
11. Howard D, Partridge K, Yang X, et al. Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold. Biochem Biophys Res Commun 2002; 299: 208-215.
12. Yang J, Huang Y, Wang XJ, et al. Dielectric properties of human leukocyte subpopulations determined by electrorotation as a cell separation criterion. Biophys J 1999; 76: 3307-3314.
13. Chan JW, Taylor DS, Lane SM, et al. Nondestructive identification of individual leukemia cells by laser trapping Raman spectroscopy. Anal Chem 2008; 80: 2180-2187.
14. Petersson F, Åberg L, Swärd-Nilsson A-M, et al. Free flow acoustophoresis: microfluidic-based mode of particle and cell separation. Anal Chem 2007; 79: 5117-5123.
15. Hu X, Bessette PH, Qian J, et al. Marker-specific sorting of rare cells using dielectrophoresis. Proc Natl Acad Sci U S A 2005; 102: 15757-15761.
16. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 2000; 97: 13625-13630.
17. Nagase K, Kimura A, Shimizu T, et al. Dynamically cell separating thermo-functional biointerfaces with densely packed polymer brushes. J Mater Chem 2012; 22: 19514-19522.
18. Miller RG and Phillips RA. Separation of cells by velocity sedimentation. J Cell Physiol 1969; 73: 191-201.
19. Buckner D, Graw RG, Eisel RJ, et al. Leukapheresis* by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood 1969; 33: 353-369.
20. Liu W, Hou Y, Chen H, et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 2011; 11: 3556-3564.
21. Strelkauskas AJ, Teodorescu M and Dray S. Enumeration and isolation of human T and B lymphocytes by rosette formation with antibody-coated erythrocytes. Clin Exp Immunol 1975; 22: 62-71.
22. Bonner WA, Sweet RG, Hulett HR, et al. Fluorescence activated cell sorting. Rev Sci Instrum 1972; 43: 404-409.
23. Miltenyi S, Müller W, Weichel W, et al. High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
24. Rembaum A, Yen RCK, Kempner DH, et al. Cell labeling and magnetic separation by means of immunoreagents based on polyacrolein microspheres. J Immunol Methods 1982; 52: 341-351.
25. Adams AA, Okagbare PI, Feng J, et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008; 130: 8633-8641.
26. Mahara A and Yamaoka T. Continuous separation of cells of high osteoblastic differentiation potential from mesenchymal stem cells on an antibody-immobilized column. Biomaterials 2010; 31: 4231-4237.
27. Kumar A and Srivastava A. Cell separation using cryogel-based affinity chromatography. Nat Protoc 2010; 5: 1737-1747.
28. Schneider T, Karl S, Moore LR, et al. Sequential CD34 cell fractionation by magnetophoresis in a magnetic dipole flow sorter. Analyst 2010; 135: 62-70.
29. Xu Y, Phillips JA, Yan JL, et al. Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem 2009; 81: 7436-7442.
30. Sousa AF, Andrade PZ, Pirzgalska RM, et al. A novel method for human hematopoietic stem/progenitor cell isolation from umbilical cord blood based on immunoaffinity aqueous two-phase partitioning. Biotechnol Lett 2011; 33: 2373-2377.
31. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992; 89: 2804-2808.
32. Gossett DR, Weaver WM, Mach AJ, et al. Label-free cell separation and sorting in microfluidic systems. Anal Bioanal Chem 2010; 397: 3249-3267.
33. Ji HM, Samper V, Chen Y, et al. Silicon-based microfilters for whole blood cell separation. Biomed Microdevices 2008; 10: 251-257.
34. Vykoukal J, Vykoukal DM, Freyberg S, et al. Enrichment of putative stem cells from adipose tissue using dielectrophoretic field-flow fractionation. Lab Chip 2008; 8: 1386-1393.
35. Lang P, Schumm M, Taylor G, et al. Clinical scale isolation of highly purified peripheral CD34+ progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant 1999; 24: 583-589.
36. Brown M and Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem 2000; 46: 1221-1229.
37. Digiusto DL and Cooper LJN. Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. Cytotherapy 2007; 9: 613-629.
38. Sharpe PT. Methods of cell separation. Amsterdam: Elsevier Science, 1988, p. 272.
39. Lucey DR, Dorsky DI, Nicholsonweller A, et al. Human eosinophils express CD4 protein and bind human immunodeficiency virus-1 gp120. J Exp Med 1989; 169: 327-332.
40. Groux H, Ogarra A, Bigler M, et al. A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742.
41. Mosmann TR and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-146.
42. Williams RC, Koster FT and Kilpatrick KA. Alterations in lymphocyte cell-surface markers during various human infections. Am J Med 1983; 75: 807-816.
43. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-636.
44. Castro-Malaspina H, Gay R, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289-301.
45. Seifalian AM, Salacinski HJ, Punshon G, et al. A new technique for measuring the cell growth and metabolism of endothelial cells seeded on vascular prostheses. J Biomed Mater Res 2001; 55: 637-644.
46. Crissman HA and Steinkamp JA. A new method for rapid and sensitive detection of bromodeoxyuridine in DNA-replicating cells. Exp Cell Res 1987; 173: 256-261.
47. Bøyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; 5: (Suppl. 5): 9-15.
48. Chatenoud L and Bluestone JA. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol 2007; 7: 622-632.
49. Rao PE, Talle MA, Kung PC, et al. Five epitopes of a differentiation antigen on human inducer T cells distinguished by monoclonal antibodies. Cell Immunol 1983; 80: 310-319.
50. Sakariassen PO, Immervoll H and Chekenya M. Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 2007; 9: 882-892.
51. Ginaldi L, De Martinis M, Matutes E, et al. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998; 51: 364-369.
52. Battula VL, Treml S, Bareiss PM, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009; 94: 173-184.
53. Nadler LM, Anderson KC, Marti G, et al. B4, a human lymphocyte-B-associated antigen expressed on normal, mitogen-activated, and malignant lymphocytes-B. J Immunol 1983; 131: 244-250.
54. Lenkei R and Andersson B. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Methods 1995; 183: 267-277.
55. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human-bone marrow 2. Normal lymphocyte-B development. Blood 1987; 70: 1316-1324.
56. Stashenko P, Nadler LM, Hardy R, et al. Characterization of a human lymphocyte-B-specific antigen. J Immunol 1980; 125: 1678-1685.
57. Greaves MF, Hariri G, Newman RA, et al. Selective expression of the common acute lymphoblastic-leukemia (gp100) antigen on immature lymphoid-cells and their malignant counterparts. Blood 1983; 61: 628-639.
58. McCloskey KE, Moore LR, Hoyos M, et al. Magnetophoretic cell sorting is a function of antibody binding capacity. Biotechnol Prog 2003; 19: 899-907.
59. Jones EA, Kinsey SE, English A, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46: 3349-3360.
60. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
61. Laiho K and Penttilä A. Autolytic changes in blood cells and other tissue cells of human cadavers. I. Viability and ion studies. Forensic Sci Int 1981; 17: 109-120.
62. Caviedes-Bucheli J, Avendaño N, Gutierrez R, et al. Quantification of lactate-dehydrogenase and cell viability in postmortem human dental pulp. J Endod 2006; 32: 183-185.
63. D'Armini AM, Tom EJ, Roberts CS, et al. When does the lung die? Time course of high energy phosphate depletion and relationship to lung viability after 'Death'. J Surg Res 1995; 59: 468-474.
64. O'Driscoll SW, Meisami B, Miura Y, et al. Viability of periosteal tissue obtained postmortem. Cell Transplant 1999; 8: 611-616.
65. Clarke C and Davies S. Immunomagnetic cell separation. In: Brooks SA and Schumacher U (eds) Metastasis research protocols. New York: Humana Press, 2001, pp. 17-23.
66. McNally RT and Brockbank KGM. Issues surrounding the preservation of viable allograft heart valves. J Med Eng Technol 1992; 16: 34-38.
67. Reuther T, Kochel M, Mueller-Richter U, et al. Cryopreservation of autologous bone grafts: an experimental study on a sheep animal model. Cells Tissues Organs 2010; 191: 394-400.
68. Chan SCW, Lam SKL, Leung VYL, et al. Minimizing cryopreservation-induced loss of disc cell activity for storage of whole intervertebral discs. Eur Cell Mater 2010; 19: 273-283.
69. Dreikorn K, Horsch R and Rohl L. 48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution. Eur Urol 1980; 6: 221-224.
70. Kischer CW, Leibovitz A and Pindur J. The use of a transport medium L14M15 for bulk tissue storage and retention of viability. Cytotechnology 1989; 2: 181-186.
71. Ozeki T, Kwon MH, Gu JY, et al. Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. Circ J 2007; 71: 153-159.
72. Kibondo A, Talbot D, Cullis-Hill D, et al. Perfusates: their properties and usage for the maintenance and storage of organs for transplantation. Curr Anaesth Crit Care 2010; 21: 216-219.
73. Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524-1527.
74. Geissmann F, Jung S and Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
75. Renner WA, Jordan M, Eppenberger HM, et al. Cell-cell adhesion and aggregation: influence on the growth behavior of CHO cells. Biotechnol Bioeng 1993; 41: 188-193.
76. Pisetsky DS and Fairhurst A-M. The origin of extracellular DNA during the clearance of dead and dying cells - review. Autoimmunity 2007; 40: 281-284.
77. Steinberg MS. 'ECM': its nature, origin and function in cell aggregation. Exp Cell Res 1963; 30: 257-279.
78. Hefeneider SH, McCoy SL, Morton JI, et al. DNA binding to mouse cells is mediated by cell-surface molecules: the role of these DNA-binding molecules as target antigens in murine lupus. Lupus 1992; 1: 167-173.
79. Klein AB, Witonsky SG, Ahmed SA, et al. Impact of different cell isolation techniques on lymphocyte viability and function. J Immunoassay Immunochem 2006; 27: 61-76.
80. Marthinuss J, Andrade-Gordon P and Seiberg M. A secreted serine protease can induce apoptosis in Pam212 keratinocytes. Cell Growth Differ 1995; 6: 807-816.
81. Noel JS, Zucker RM, Wu NC, et al. The dissociation of transplantable tumors. J Histochem Cytochem 1977; 25: 544-553.
82. Booth C, O'Shea JA and Potten CS. Maintenance of functional stem cells in isolated and cultured adult intestinal epithelium. Exp Cell Res 1999; 249: 359-366.
83. Stewart CC and Stewart SJ. Multiparameter analysis of leukocytes by flow cytometry. Methods Cell Biol 1994; 41: 61-79.
84. Tennant JR. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964; 2: 685-694.
85. Van Hooijdonk CAEM, Glade CP and Van Erp PEJ. TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 1994; 17: 185-189.
86. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279.
87. Papadopoulos NG, Dedoussis GVZ, Spanakos G, et al. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow-cytometry. J Immunol Methods 1994; 177: 101-111.
88. Schmid I, Krall WJ, Uittenbogaart CH, et al. Dead cell discrimination with 7-amino-actinomycin-D in combination with dual color immunofluorescence in single laser flow-cytometry. Cytometry 1992; 13: 204-208.
89. Perfetto SP, Chattopadhyay PK, Lamoreaux L, et al. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods 2006; 313: 199-208.
90. Koopman G, Reutelingsperger CPM, Kuijten GAM, et al. Annexin-V for flow cytometric detection of phosphatidylserine expression on B-cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
91. Shafiee H, Sano MB, Henslee EA, et al. Selective isolation of live/dead cells using contactless dielectrophoresis (cDEP). Lab Chip 2010; 10: 438-445.
92. Kose AR, Fischer B, Mao L, et al. Label-free cellular manipulation and sorting via biocompatible ferrofluids. Proc Natl Acad Sci U S A 2009; 106: 21478-21483.
93. Fridman W. Fc receptors and immunoglobulin binding factors. FASEB J 1991; 5: 2684-2690.
94. Daëron M. Fc receptor biology. Annu Rev Immunol 1997; 15: 203-234.
95. Ravetch JV and Kinet JP. Fc-receptors. Annu Rev Immunol 1991; 9: 457-492.
96. Heyman B. Complement and Fc-receptors in regulation of the antibody response. Immunol Lett 1996; 54: 195-199.